The global Surgical Treatment of Dermatophytosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Dermatophytic Onychomycosis Therapeutic Lasers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Surgical Treatment of Dermatophytosis include Bausch Health, Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd. and Medimetriks Pharmaceuticals, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Surgical Treatment of Dermatophytosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Treatment of Dermatophytosis. This report contains market size and forecasts of Surgical Treatment of Dermatophytosis in global, including the following market information:
Global Surgical Treatment of Dermatophytosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Surgical Treatment of Dermatophytosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Surgical Treatment of Dermatophytosis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Surgical Treatment of Dermatophytosis Market Segment Percentages, by Type, 2022 (%)
Dermatophytic Onychomycosis Therapeutic Lasers
Photodynamic Therapy
Global Surgical Treatment of Dermatophytosis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Surgical Treatment of Dermatophytosis Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Surgical Treatment of Dermatophytosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Surgical Treatment of Dermatophytosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Surgical Treatment of Dermatophytosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Surgical Treatment of Dermatophytosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Galderma S.A.
Novartis AG
Pfizer, Inc.
Moberg Pharma AB
Bayer AG
Dr. Reddy’s Laboratories Ltd.
Cipla Ltd.
Medimetriks Pharmaceuticals, Inc.
Sanofi S.A.
GlaxoSmithKline Plc.
Teva Pharmaceutical industries Ltd.
Cardinal Health Inc.
Viatris Inc.
Almirall, S.A
Outline of Major Chapters:
Chapter 1: Introduces the definition of Surgical Treatment of Dermatophytosis, market overview.
Chapter 2: Global Surgical Treatment of Dermatophytosis market size in revenue.
Chapter 3: Detailed analysis of Surgical Treatment of Dermatophytosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Surgical Treatment of Dermatophytosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Surgical Treatment of Dermatophytosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Surgical Treatment of Dermatophytosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Surgical Treatment of Dermatophytosis Overall Market Size
2.1 Global Surgical Treatment of Dermatophytosis Market Size: 2022 VS 2029
2.2 Global Surgical Treatment of Dermatophytosis Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Surgical Treatment of Dermatophytosis Players in Global Market
3.2 Top Global Surgical Treatment of Dermatophytosis Companies Ranked by Revenue
3.3 Global Surgical Treatment of Dermatophytosis Revenue by Companies
3.4 Top 3 and Top 5 Surgical Treatment of Dermatophytosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Surgical Treatment of Dermatophytosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Surgical Treatment of Dermatophytosis Players in Global Market
3.6.1 List of Global Tier 1 Surgical Treatment of Dermatophytosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Surgical Treatment of Dermatophytosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Surgical Treatment of Dermatophytosis Market Size Markets, 2022 & 2029
4.1.2 Dermatophytic Onychomycosis Therapeutic Lasers
4.1.3 Photodynamic Therapy
4.2 By Type - Global Surgical Treatment of Dermatophytosis Revenue & Forecasts
4.2.1 By Type - Global Surgical Treatment of Dermatophytosis Revenue, 2018-2023
4.2.2 By Type - Global Surgical Treatment of Dermatophytosis Revenue, 2024-2029
4.2.3 By Type - Global Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Surgical Treatment of Dermatophytosis Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Surgical Treatment of Dermatophytosis Revenue & Forecasts
5.2.1 By Application - Global Surgical Treatment of Dermatophytosis Revenue, 2018-2023
5.2.2 By Application - Global Surgical Treatment of Dermatophytosis Revenue, 2024-2029
5.2.3 By Application - Global Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Surgical Treatment of Dermatophytosis Market Size, 2022 & 2029
6.2 By Region - Global Surgical Treatment of Dermatophytosis Revenue & Forecasts
6.2.1 By Region - Global Surgical Treatment of Dermatophytosis Revenue, 2018-2023
6.2.2 By Region - Global Surgical Treatment of Dermatophytosis Revenue, 2024-2029
6.2.3 By Region - Global Surgical Treatment of Dermatophytosis Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Surgical Treatment of Dermatophytosis Revenue, 2018-2029
6.3.2 US Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.3.3 Canada Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.3.4 Mexico Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Surgical Treatment of Dermatophytosis Revenue, 2018-2029
6.4.2 Germany Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.4.3 France Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.4.4 U.K. Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.4.5 Italy Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.4.6 Russia Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.4.7 Nordic Countries Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.4.8 Benelux Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Surgical Treatment of Dermatophytosis Revenue, 2018-2029
6.5.2 China Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.5.3 Japan Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.5.4 South Korea Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.5.5 Southeast Asia Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.5.6 India Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Surgical Treatment of Dermatophytosis Revenue, 2018-2029
6.6.2 Brazil Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.6.3 Argentina Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Surgical Treatment of Dermatophytosis Revenue, 2018-2029
6.7.2 Turkey Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.7.3 Israel Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.7.4 Saudi Arabia Surgical Treatment of Dermatophytosis Market Size, 2018-2029
6.7.5 UAE Surgical Treatment of Dermatophytosis Market Size, 2018-2029
7 Surgical Treatment of Dermatophytosis Companies Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Surgical Treatment of Dermatophytosis Major Product Offerings
7.1.4 Bausch Health Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.1.5 Bausch Health Key News & Latest Developments
7.2 Galderma S.A.
7.2.1 Galderma S.A. Company Summary
7.2.2 Galderma S.A. Business Overview
7.2.3 Galderma S.A. Surgical Treatment of Dermatophytosis Major Product Offerings
7.2.4 Galderma S.A. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.2.5 Galderma S.A. Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Surgical Treatment of Dermatophytosis Major Product Offerings
7.3.4 Novartis AG Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Pfizer, Inc.
7.4.1 Pfizer, Inc. Company Summary
7.4.2 Pfizer, Inc. Business Overview
7.4.3 Pfizer, Inc. Surgical Treatment of Dermatophytosis Major Product Offerings
7.4.4 Pfizer, Inc. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.4.5 Pfizer, Inc. Key News & Latest Developments
7.5 Moberg Pharma AB
7.5.1 Moberg Pharma AB Company Summary
7.5.2 Moberg Pharma AB Business Overview
7.5.3 Moberg Pharma AB Surgical Treatment of Dermatophytosis Major Product Offerings
7.5.4 Moberg Pharma AB Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.5.5 Moberg Pharma AB Key News & Latest Developments
7.6 Bayer AG
7.6.1 Bayer AG Company Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Surgical Treatment of Dermatophytosis Major Product Offerings
7.6.4 Bayer AG Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.6.5 Bayer AG Key News & Latest Developments
7.7 Dr. Reddy’s Laboratories Ltd.
7.7.1 Dr. Reddy’s Laboratories Ltd. Company Summary
7.7.2 Dr. Reddy’s Laboratories Ltd. Business Overview
7.7.3 Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Major Product Offerings
7.7.4 Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.7.5 Dr. Reddy’s Laboratories Ltd. Key News & Latest Developments
7.8 Cipla Ltd.
7.8.1 Cipla Ltd. Company Summary
7.8.2 Cipla Ltd. Business Overview
7.8.3 Cipla Ltd. Surgical Treatment of Dermatophytosis Major Product Offerings
7.8.4 Cipla Ltd. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.8.5 Cipla Ltd. Key News & Latest Developments
7.9 Medimetriks Pharmaceuticals, Inc.
7.9.1 Medimetriks Pharmaceuticals, Inc. Company Summary
7.9.2 Medimetriks Pharmaceuticals, Inc. Business Overview
7.9.3 Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Major Product Offerings
7.9.4 Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.9.5 Medimetriks Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Sanofi S.A.
7.10.1 Sanofi S.A. Company Summary
7.10.2 Sanofi S.A. Business Overview
7.10.3 Sanofi S.A. Surgical Treatment of Dermatophytosis Major Product Offerings
7.10.4 Sanofi S.A. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.10.5 Sanofi S.A. Key News & Latest Developments
7.11 GlaxoSmithKline Plc.
7.11.1 GlaxoSmithKline Plc. Company Summary
7.11.2 GlaxoSmithKline Plc. Business Overview
7.11.3 GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Major Product Offerings
7.11.4 GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.11.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.12 Teva Pharmaceutical industries Ltd.
7.12.1 Teva Pharmaceutical industries Ltd. Company Summary
7.12.2 Teva Pharmaceutical industries Ltd. Business Overview
7.12.3 Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Major Product Offerings
7.12.4 Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.12.5 Teva Pharmaceutical industries Ltd. Key News & Latest Developments
7.13 Cardinal Health Inc.
7.13.1 Cardinal Health Inc. Company Summary
7.13.2 Cardinal Health Inc. Business Overview
7.13.3 Cardinal Health Inc. Surgical Treatment of Dermatophytosis Major Product Offerings
7.13.4 Cardinal Health Inc. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.13.5 Cardinal Health Inc. Key News & Latest Developments
7.14 Viatris Inc.
7.14.1 Viatris Inc. Company Summary
7.14.2 Viatris Inc. Business Overview
7.14.3 Viatris Inc. Surgical Treatment of Dermatophytosis Major Product Offerings
7.14.4 Viatris Inc. Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.14.5 Viatris Inc. Key News & Latest Developments
7.15 Almirall, S.A
7.15.1 Almirall, S.A Company Summary
7.15.2 Almirall, S.A Business Overview
7.15.3 Almirall, S.A Surgical Treatment of Dermatophytosis Major Product Offerings
7.15.4 Almirall, S.A Surgical Treatment of Dermatophytosis Revenue in Global Market (2018-2023)
7.15.5 Almirall, S.A Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report